Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel
1 other identifier
observational
50
1 country
1
Brief Summary
The study intends to summarize the clinical and laboratory characteristics of children with hemolytic anemia diagnosed as having alpha thalassemia mutations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2009
CompletedFirst Posted
Study publicly available on registry
September 4, 2009
CompletedStudy Start
First participant enrolled
October 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedSeptember 1, 2015
August 1, 2015
2.5 years
September 3, 2009
August 30, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Analysis of the Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia
Analysis of the Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia
One year
Study Arms (1)
Alpha thalassemia patients
Patients diagnosed with alpha thalassemia mutations and anemia
Interventions
Summary of Medical files and laboratory results.
Eligibility Criteria
A group of 50 children that underwent workup due to hemolytic anemia and were further diagnosis as suffering from clinical alpha thalassemia.
You may qualify if:
- All the patients that were studied at the pediatric hematology unit ant the Ha'Emek Medical Center
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, 18101, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Pediatric Hematology Unit and Pediatric Dpt B
Study Record Dates
First Submitted
September 3, 2009
First Posted
September 4, 2009
Study Start
October 1, 2009
Primary Completion
April 1, 2012
Study Completion
April 1, 2012
Last Updated
September 1, 2015
Record last verified: 2015-08